Tianda Pharmaceuticals Limited (HKG:0455)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0910
+0.0020 (2.25%)
Jun 18, 2026, 6:07 PM HKT
Market Cap195.65M -39.3%
Revenue (ttm)322.95M -2.1%
Net Income-70.00M
EPS-0.03
Shares Out 2.15B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume126,000
Open0.0910
Previous Close0.0890
Day's Range0.0910 - 0.0950
52-Week Range0.0810 - 0.2150
Beta-0.08
AnalystsStrong Buy
Price Target0.65 (+614.29%)
Earnings DateAug 28, 2026

About Tianda Pharmaceuticals

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine; Pharmaceuticals and Medical Technologies; and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products foc... [Read more]

Sector Healthcare
Founded 1992
Employees 613
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0455
Full Company Profile

Financial Performance

In 2025, Tianda Pharmaceuticals's revenue was 322.95 million, a decrease of -2.12% compared to the previous year's 329.94 million. Losses were -70.00 million, 14.1% more than in 2024.

Financial Statements